Dr. Bradley A McGregor, MD
Claim this profileDana Farber Cancer Institute
Studies Kidney Cancer
Studies Renal Cell Carcinoma
7 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Bradley A McGregor, MD is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Sacituzumab Govitecan + Enfortumab Vedotin
for Bladder Cancer
Phase I of this research study will assess what doses of Sacituzumab Govitecan and Enfortumab Vedotin can be safely combined in the treatment of metastatic urothelial carcinoma (mUC). In Phase II of the study, patients in one of the two cohorts will receive Sacituzumab Govitecan, Enfortumab Vedotin, and Pembrolizumab to assess the efficacy of this drug combination. The names of the study drugs in these investigational combinations are: * Enfortumab Vedotin * Sacituzumab Govitecan * Pembrolizumab
Recruiting1 award Phase 1 & 216 criteria
More about Bradley A McGregor, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Bradley A McGregor, MD has experience with
- Ipilimumab
- Nivolumab
- Cabozantinib
- Enfortumab Vedotin
- Sacituzumab Govitecan
- TAK-228
Breakdown of trials Bradley A McGregor, MD has run
Kidney Cancer
Renal Cell Carcinoma
Bladder Cancer
Kidney Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bradley A McGregor, MD specialize in?
Bradley A McGregor, MD focuses on Kidney Cancer and Renal Cell Carcinoma. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Bradley A McGregor, MD currently recruiting for clinical trials?
Yes, Bradley A McGregor, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Bradley A McGregor, MD has studied deeply?
Yes, Bradley A McGregor, MD has studied treatments such as Ipilimumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Bradley A McGregor, MD?
Apply for one of the trials that Bradley A McGregor, MD is conducting.
What is the office address of Bradley A McGregor, MD?
The office of Bradley A McGregor, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.